Pseudechis porphyriacus cytotoxic and hemolytic venom proteins

The cytotoxic and hemolytic proteins of the Red-bellied Black Snake (Pseudechis porphyriacus) represent a group of toxic components primarily dominated by Phospholipase A2 (PLA2) enzymes, such as pseudexin. These proteins function by hydrolyzing phospholipids in cell membranes, leading to direct cell lysis, myotoxicity, and the destruction of red blood cells, known as hemolysis (Source: UniProt, Clinical Toxinology Resources). In clinical envenomation, these toxins cause local pain, swelling, and systemic effects including rhabdomyolysis and potential secondary renal failure (Source: PubMed, PMID: 22449298). While not therapeutic targets in the traditional sense of human disease management, they are the primary targets for neutralization by antivenoms, such as the Black Snake or Tiger Snake antivenoms used in Australia (Source: Toxinology.com). Additionally, small molecule inhibitors like Varespladib are being researched for their ability to specifically target the PLA2 components of this venom to prevent systemic damage (Source: PubMed, PMID: 27373933). Understanding these proteins is crucial for improving snakebite treatment and exploring their potential as biochemical probes.

Other names

Red-bellied black snake venom toxinsPseudechis porphyriacus hemolysinsPseudechis porphyriacus cytotoxinsPseudexin-like proteinsP. porphyriacus PLA2 toxins

Neutralization of venom toxins by polyclonal antibodies (antivenom) to prevent binding to host tissues, or competitive inhibition of phospholipase A2 enzymatic activity by small molecules like Varespladib.